Search research articles
Contact Us
Filters
Showing results (31-40 of 325) with videos related to
Page
of 33
Sort By:
Nutrients
|
May 5, 2021
Genetic Evidence Supporting Fibroblast Growth Factor 21 Signalling as a Pharmacological Target for Cardiometabolic Outcomes and Alzheimer's Disease
Susanna C Larsson, Dipender Gill
Expert Opinion on Therapeutic Targets
|
June 22, 2010
Induction of pathogenic cytotoxic T lymphocyte tolerance by dendritic cells: a novel therapeutic target
Dipender Gill, Peng H Tan
Allergy
|
December 31, 2020
Genetic predisposition to allergic diseases is inversely associated with risk of COVID-19
Susanna C Larsson, Dipender Gill
Stroke
|
August 17, 2021
Mendelian Randomization Studies in Stroke: Exploration of Risk Factors and Drug Targets With Human Genetic Data
Marios K Georgakis, Dipender Gill
BMJ (Clinical Research Ed.)
|
December 14, 2020
Testing for antibodies to SARS-CoV-2
Dipender Gill, Mark J Ponsford
Annals of the Rheumatic Diseases
|
June 14, 2022
Genetically proxied IL-6 receptor inhibition and risk of polymyalgia rheumatica
Sizheng Steven Zhao, Dipender Gill
BMJ (Clinical Research Ed.)
|
September 3, 2021
Ronapreve for prophylaxis and treatment of covid-19
David B Sidebottom, Dipender Gill
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 2, 2023
Role of Clonal Hematopoiesis of Indeterminant Potential-Related Germline <i>TET2</i> Variation in Inflammation and Cardiovascular Disease Risk: A Mendelian Randomization Study
Héléne T Cronjé, Dipender Gill
The Clinical Teacher
|
November 22, 2012
Fixing a peer-led teaching day into the calendar
Dipender Gill, Eugene Ong, Jon Cleland
International Journal of Epidemiology
|
March 30, 2025
Why exposure misidentification is a pervasive pitfall of Mendelian randomization studies with medication use as the exposure
Benjamin Woolf, James Yarmolinsky, Dipender Gill
Page
of 33
Search research articles
Search
Showing results (31-40 of 325) with videos related to
Sort By:
Page
of 33
Nutrients
|
May 5, 2021
Genetic Evidence Supporting Fibroblast Growth Factor 21 Signalling as a Pharmacological Target for Cardiometabolic Outcomes and Alzheimer's Disease
Susanna C Larsson, Dipender Gill
Expert Opinion on Therapeutic Targets
|
June 22, 2010
Induction of pathogenic cytotoxic T lymphocyte tolerance by dendritic cells: a novel therapeutic target
Dipender Gill, Peng H Tan
Allergy
|
December 31, 2020
Genetic predisposition to allergic diseases is inversely associated with risk of COVID-19
Susanna C Larsson, Dipender Gill
Stroke
|
August 17, 2021
Mendelian Randomization Studies in Stroke: Exploration of Risk Factors and Drug Targets With Human Genetic Data
Marios K Georgakis, Dipender Gill
BMJ (Clinical Research Ed.)
|
December 14, 2020
Testing for antibodies to SARS-CoV-2
Dipender Gill, Mark J Ponsford
Annals of the Rheumatic Diseases
|
June 14, 2022
Genetically proxied IL-6 receptor inhibition and risk of polymyalgia rheumatica
Sizheng Steven Zhao, Dipender Gill
BMJ (Clinical Research Ed.)
|
September 3, 2021
Ronapreve for prophylaxis and treatment of covid-19
David B Sidebottom, Dipender Gill
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 2, 2023
Role of Clonal Hematopoiesis of Indeterminant Potential-Related Germline <i>TET2</i> Variation in Inflammation and Cardiovascular Disease Risk: A Mendelian Randomization Study
Héléne T Cronjé, Dipender Gill
The Clinical Teacher
|
November 22, 2012
Fixing a peer-led teaching day into the calendar
Dipender Gill, Eugene Ong, Jon Cleland
International Journal of Epidemiology
|
March 30, 2025
Why exposure misidentification is a pervasive pitfall of Mendelian randomization studies with medication use as the exposure
Benjamin Woolf, James Yarmolinsky, Dipender Gill
Page
of 33